These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 29233480)

  • 21. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global estimates on the number of persons across the Alzheimer's disease continuum.
    Gustavsson A; Norton N; Fast T; Frölich L; Georges J; Holzapfel D; Kirabali T; Krolak-Salmon P; Rossini PM; Ferretti MT; Lanman L; Chadha AS; van der Flier WM
    Alzheimers Dement; 2023 Feb; 19(2):658-670. PubMed ID: 35652476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.
    Wang D; Schultz T; Novak GP; Baker S; Bennett DA; Narayan VA
    J Alzheimers Dis; 2018; 62(2):855-865. PubMed ID: 29480187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2012 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2012; 8(2):131-68. PubMed ID: 22404854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2014 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2014 Mar; 10(2):e47-92. PubMed ID: 24818261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States.
    Wilson RS; Weir DR; Leurgans SE; Evans DA; Hebert LE; Langa KM; Plassman BL; Small BJ; Bennett DA
    Alzheimers Dement; 2011 Jan; 7(1):74-9. PubMed ID: 21255745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the risk for conversion from mild cognitive impairment to Alzheimer's disease in an elderly Arab community.
    Inzelberg R; Massarwa M; Schechtman E; Strugatsky R; Farrer LA; Friedland RP
    J Alzheimers Dis; 2015; 45(3):865-71. PubMed ID: 25624416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinction between preclinical Alzheimer's disease and depression.
    Visser PJ; Verhey FR; Ponds RW; Kester A; Jolles J
    J Am Geriatr Soc; 2000 May; 48(5):479-84. PubMed ID: 10811539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.
    Knopman DS; Jack CR; Wiste HJ; Weigand SD; Vemuri P; Lowe V; Kantarci K; Gunter JL; Senjem ML; Ivnik RJ; Roberts RO; Boeve BF; Petersen RC
    Neurology; 2012 May; 78(20):1576-82. PubMed ID: 22551733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deaths in the United States among persons with Alzheimer's disease (2010-2050).
    Weuve J; Hebert LE; Scherr PA; Evans DA
    Alzheimers Dement; 2014 Mar; 10(2):e40-6. PubMed ID: 24698031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal verbal fluency in normal aging, preclinical, and prevalent Alzheimer's disease.
    Clark LJ; Gatz M; Zheng L; Chen YL; McCleary C; Mack WJ
    Am J Alzheimers Dis Other Demen; 2009 Dec-2010 Jan; 24(6):461-8. PubMed ID: 19759254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.
    Vogel JW; Vachon-Presseau E; Pichet Binette A; Tam A; Orban P; La Joie R; Savard M; Picard C; Poirier J; Bellec P; Breitner JCS; Villeneuve S;
    Brain; 2018 Jun; 141(6):1871-1883. PubMed ID: 29688388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive deficits in preclinical Alzheimer's disease.
    Small BJ; Mobly JL; Laukka EJ; Jones S; Bäckman L
    Acta Neurol Scand Suppl; 2003; 179():29-33. PubMed ID: 12603248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early symptoms and signs of cognitive deficits might not always be detectable in persons who develop Alzheimer's disease.
    Palmer K; Bäckman L; Winblad B; Fratiglioni L
    Int Psychogeriatr; 2008 Apr; 20(2):252-8. PubMed ID: 18257960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of Alzheimer's disease: population-based estimates and projections for New Zealand, 2006-2031.
    Tobias M; Yeh LC; Johnson E
    Aust N Z J Psychiatry; 2008 Sep; 42(9):828-36. PubMed ID: 18696288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropathology of older persons without cognitive impairment from two community-based studies.
    Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS
    Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2022 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2022 Apr; 18(4):700-789. PubMed ID: 35289055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer disease in the US population: prevalence estimates using the 2000 census.
    Hebert LE; Scherr PA; Bienias JL; Bennett DA; Evans DA
    Arch Neurol; 2003 Aug; 60(8):1119-22. PubMed ID: 12925369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.